{"url_path":"/sec/rani/8-k/2026-05-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1856725/0001193125-26-226691-index.html","accession_number":"0001193125-26-226691","cik":"0001856725","ticker":"RANI","issuer_name":"Rani Therapeutics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1856725/0001193125-26-226691-index.html","primary_entity_key":"0001856725","primary_entity_name":"Rani Therapeutics Holdings, Inc."},"word_count":84,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\nExhibit Description\n\n99.1\n\n[Press Release of Rani Therapeutics Holdings, Inc. dated May 15, 2026](rani-ex99_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \n\n \n\nRani Therapeutics Holdings, Inc.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 15, 2026\n\nBy:\n\n/s/ Talat Imran\n\n \n\n \n\n \n\nTalat Imran\nChief Executive Officer"}